UNSPSC 51151668: Trimebutine
Commodity
Code facts
- Part of
-
-
51000000
-
51150000
- 51151600
-
51150000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51151668
| NIGP code |
|---|
| 26912 Autonomic Drugs |
Definition
This classification denotes an opioid receptor agonist with the molecular formula C22H29NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QZ1OJ92E5R, chemically known as 3,4,5-trimethoxybenzoic acid 2-(dimethylamino)-2-phenylbutyl ester but generally known as trimebutine, which bears US NIH Compound Identifier 5573. European Medicines Agency schedules Trimebutine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11299MIG.
Read the full definition
The term TRIMEBUTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). World Health Organization schedules trimebutine in its Anatomical Therapeutic Chemical (ATC) Classification. TRIMEBUTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule trimebutine under HS 29221980 and SITC 51461. As of Q4 2014, TRIMEBUTINE remains the US FDA Preferred Term for this commodity.
Trimebutine bears US NLM identifiers UMLS ID C0041023 and NCI Concept Code C80588. SMILES: O(CC(N(C)C)(CC)C1CCCCC1)C(=O)C1CC(OC)C(OC)C(OC)C1.
About UNSPSC 51151668
UNSPSC 51151668 Trimebutine is a Commodity code that captures pharmaceutical products — specifically trimebutine and related medications — procured by state and local health agencies. Recent state and local activity under this code shows health departments and county health systems buying naloxone, drug deactivation systems, and pharmacy benefit management services to support community health initiatives and prescription fulfillment programs. The issuing bodies include county health departments and state health and human services commissions. Seminole County, Florida and the Texas Health and Human Services Commission represent the kinds of jurisdictions acquiring products or services tagged to this code.
Activity clusters in Florida and Texas. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2023 — the contract carries a two-year initial term plus one-year renewal option and is potentially FEMA-funded. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program that would establish direct relationships between the state pharmacy benefit program and pharmaceutical manufacturers to improve prescription fulfillment and cost management. The RFI is exploratory; no formal award value or contract duration is specified at this stage.
Quick answers
What is UNSPSC 51151668?
UNSPSC 51151668 is Trimebutine, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51151668?
UNSPSC 51151668 maps to 1 NIGP code, 26912 Autonomic Drugs.
On GovTribe
See everything under UNSPSC 51151668
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code